6USX
Identification of the Clinical Development Candidate MRTX849, a Covalent KRASG12C Inhibitor for the Treatment of Cancer
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU FR-E |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2019-01-30 |
Detector | DECTRIS PILATUS 2M |
Wavelength(s) | 1.5418 |
Spacegroup name | C 2 2 2 |
Unit cell lengths | 88.570, 156.490, 62.980 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 29.510 - 2.270 |
Rwork | 0.187 |
R-free | 0.24980 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 4l8g.pdb |
RMSD bond length | 0.011 |
RMSD bond angle | 1.945 |
Data reduction software | iMOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (5.8.0253) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 30.000 | 2.420 |
High resolution limit [Å] | 2.270 | 2.270 |
Rmeas | 0.250 | 0.250 |
Rpim | 0.135 | 0.135 |
Number of reflections | 32164 | 2587 |
<I/σ(I)> | 9.72 | 4.7 |
Completeness [%] | 84.7 | 69 |
Redundancy | 3.65 | 3.3 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5.4 | 293 | 29% PEG8K 0.1M NaCitrate pH 5.4 0.2M Amm Acetate |